Back to News
Market Impact: 0.08
Texas Cardiac Arrhythmia Institute pri St. David's Medical Center sa zúčastňuje na skúšaní inovatívneho mapovacieho a pulzného ablačného systému ako prvý v USA
Source: PR Newswire
Healthcare & BiotechTechnology & Innovation
Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center announced it became the first site in the country to participate in a clinical trial evaluating the safety and efficacy of a mapping and pulsed ablation system. The release is primarily institutional/clinical trial participation news without reported outcomes, financial figures, or broader market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- CNBC Daily Open: Sanctions, strikes and the road to $100 oil
- Nvidia Earnings Blow Everyone Away
- China's EV makers shift gears to focus on humanoids as car market slows
- OpenAI says working with Samsung on next-generation chips, deepening cooperation
- Archer Aviation Is Buying Boeing's Wisk Aero, Insitu, and SkyGrid. What Does It Mean for Archer Aviation Stock?
- Broadcom's $230 Billion AI Bet Gets Real